Stockscreener 앱 받기
177.49
1.82%
-3.15
전일 마감가:
$180.64
열려 있는:
$177.45
하루 거래량:
175.80K
Relative Volume:
0.11
시가총액:
$29.63B
수익:
$16.63B
순이익/손실:
$1.39B
주가수익비율:
22.00
EPS:
8.0674
순현금흐름:
$2.12B
1주 성능:
+7.08%
1개월 성능:
+12.41%
6개월 성능:
-21.95%
1년 성능:
+24.21%
1일 변동 폭
$174.10
$178.88
1주일 범위
$163.95
$188.86
52주 변동 폭
$143.00
$247.04
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
177.52 | 30.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
472.99 | 179.15B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
175.55 | 124.65B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
554.27 | 43.45B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.41 | 38.14B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
370.56 | 36.52B | 3.77B | 449.25M | 240.68M | 7.8556 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-03-06 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2026-03-03 | 개시 | RBC Capital Mkts | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-03 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
HSBC Adjusts Price Target on IQVIA to $210 From $240, Maintains Buy Rating - marketscreener.com
IQVIA unit announces senior notes offering - MSN
IQVIA Holdings (IQV) Plans €950M Senior Notes Offering for Debt Refinancing - GuruFocus
IQVIA plans €950 million senior notes offering due 2033 - Investing.com UK
IQVIA to Raise $1.10 Billion in Debt Offering - marketscreener.com
Inside IQVIA’s €950M notes plan to refinance existing debt - Stock Titan
IQVIA Announces Offering of Senior Notes - lincolnjournal.com
Is IQVIA Holdings Inc (IQV) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA Holdings earnings preview: What to expect - MSN
Here's why IQVIA Holdings (IQV) is a strong value stock - MSN
IQVIA Holdings, Inc. (IQV) Stock Analysis: A 25% Upside Potential Amid Strong Analyst Ratings - DirectorsTalk Interviews
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
Is It Too Late To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)? - Yahoo Finance
CNIL fines IQVIA €5M for health data warehouse breaches - PPC Land
IQVIA Holdings Hits Day High with 9.34% Surge in Strong Intraday Performance - Markets Mojo
Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise? - TradingView
IQVIA Holdings Inc stock (US46266C1053): shares advance after recent outlook hike and buyback suppor - AD HOC NEWS
IQVIA Holdings Inc (IQV) Stock Up 9.3% and Still Undervalued -- GF Score: 84/100 - GuruFocus
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Rose 6% This Week. Here’s How Much the Stock Could Rise in 2026 - TIKR.com
IQVIA Jumps 9.3% as Investors Refocus on Raised 2026 Profit Outlook and Buyback Support - Moomoo
IQVIA jumps 9.3% as investors refocus on raised 2026 profit outlook and buyback support - Quiver Quantitative
IQVIA Holdings Jumps 5.7% Amid Sector-Wide Rally - AlphaStreet
Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now - TradingView
Analysts Are Bullish on Top Healthcare Stocks: IQVIA Holdings (IQV), Lantheus (LNTH) - The Globe and Mail
IQVIA CEO to Speak at Jefferies Global Healthcare Conference 2026 - BioSpace
IQVIA Holdings Inc (IQV) Stock Down 3.5% -- Now Undervalued? GF Score: 86/100 - GuruFocus
IQVIA CEO to Speak at Jefferies Global Healthcare Conference - pharmiweb.com
JPMorgan Mid Cap Equity Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term - Yahoo Finance
What Makes IQVIA Holdings (IQV) an Investment Bet? - Insider Monkey
IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant - DirectorsTalk Interviews
Liquidity Mapping Around (IQV) Price Events - Stock Traders Daily
IQVIA signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue - MSN
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Beta Bionics, Inc. (BBNX) and Twist Bioscience (TWST) - The Globe and Mail
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Holdings Inc stock (US46266C1053): data-driven healthcare group in focus after latest earnings - AD HOC NEWS
Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink? - Barchart.com
IQVIA’s SWOT analysis: healthcare stock faces margin pressures - Investing.com
IQVIA: The Market May Be Missing The AI And Data Story (NYSE:IQV) - Seeking Alpha
Research Alert: CFRA Moderates Rating On Shares Of Iqvia Holdings Inc. To Hold From Buy - Moomoo
IQVIA Holdings stock (US46266C1053): latest earnings highlight data strength and AI ambitions - AD HOC NEWS
IQVIA Signals Confidence with $3.2 Billion Share Repurchase War Chest - BriefGlance
IQVIA (IQV) Fell Despite Strong Fundamentals - Insider Monkey
IQVIA Holdings, Inc. (IQV) Stock Analysis: Growth Potential and Analyst Consensus Point to 35% Upside - DirectorsTalk Interviews
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.77%
0.42%
자본화:
|
볼륨(24시간):